Researchers launch trial to see if blood test can detect cancer left behind after treatment

Princess Margaret Cancer Centre is running a large trial to test whether a blood test can detect trace residual cancer after treatment. If successful, the approach could improve post-therapy monitoring, but the article provides no readout or timelines yet. Overall, this is early positive clinical development with limited near-term market impact.

Analysis

Princess Margaret Cancer Centre is running a large trial to test whether a blood test can detect trace residual cancer after treatment. If successful, the approach could improve post-therapy monitoring, but the article provides no readout or timelines yet. Overall, this is early positive clinical development with limited near-term market impact.